Metzger Michael A
Transaction: 07/08/2026
BUY
Change
+32,375
Price
$6.38
Filing
07/09/2026
Type
BUY
Syndax Pharmaceuticals, Inc.
SNDX • Biotechnology
$20.56
▼ -0.12 (-0.58%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.83B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Healthy liquidity · 4.4High debt level · 5.36Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:57 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$20.56
Change-0.58%
Shares Out88.99M
Market Cap$1.83B
Enterprise Value$1.87B
52W Range12.10 - 25.59
Beta0.37
P/E-8.29
P/S7.26
P/B121.18
P/FCF-8.28
EV/Sales7.42
Price$20.56
Change-0.58%
Shares Out88.99M
Market Cap$1.83B
Enterprise Value$1.87B
52W Range12.10 - 25.59
Beta0.37
P/E-8.29
P/S7.26
P/B121.18
P/FCF-8.28
EV/Sales7.42
EV/EBITDA-13.83
EV/FCF-8.47
Earnings Yield-12.07%
FCF Yield-12.07%
Dividend Yield0.00%
Gross Margin95.96%
Oper. Margin-158.45%
Profit Margin-165.60%
Debt/Eq5.36
Current Ratio4.40
Quick Ratio4.12
Target$37.00
Target Upside79.96%
Target Median$37.00
Target Range31.00 - 46.00
Volume3.77M
Avg Volume1.93M
EPS Surprise0.11
Investment DNA
How strong this company looks for long-term investors
28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 4.4High debt level · 5.36Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 22 analyst votes · 2026-09-05
95/100
Bullish
Bullish
20
Hold
2
Bearish
0
Price Target
2026-08-06
Low
$31.00
Mean
$38.00
Median
$37.50
High
$46.00
Insider Transactions
Recent executive and insider activity
Metzger Michael A
Transaction: 07/08/2026
SELL
Change
-32,375
Price
$24.24
Filing
07/09/2026
Type
SELL
Botwood Nicholas A.J.
Transaction: 06/12/2026
BUY
Change
+31,235
Price
$13.82
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Metzger Michael A | BUY | +32,375 | $6.38 | 07/08/2026 | 07/09/2026 |
| Metzger Michael A | SELL | -32,375 | $24.24 | 07/08/2026 | 07/09/2026 |
| Botwood Nicholas A.J. | BUY | +31,235 | $13.82 | 06/12/2026 | 06/12/2026 |
| Botwood Nicholas A.J. | SELL | -31,235 | $18.14 | 06/12/2026 | 06/12/2026 |
| Botwood Nicholas A.J. | SELL | -34,280 | $18.00 | 06/11/2026 | 06/12/2026 |
| Metzger Michael A | SELL | -6,847 | $18.99 | 06/01/2026 | 06/02/2026 |
| Goldan Keith A. | SELL | -1,177 | $18.99 | 06/01/2026 | 06/02/2026 |
| Goldan Keith A. | SELL | -3,410 | $21.03 | 02/09/2026 | 02/10/2026 |
| Metzger Michael A | SELL | -17,159 | $21.03 | 02/09/2026 | 02/10/2026 |
| Goldan Keith A. | SELL | -2,082 | $20.62 | 02/06/2026 | 02/06/2026 |
| Metzger Michael A | SELL | -7,412 | $20.62 | 02/06/2026 | 02/06/2026 |
| Legault Pierre | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Katkin Keith | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Rizo Aleksandra | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Podlesak Dennis | BUY | +48,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Botwood Nicholas A.J. | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Botwood Nicholas A.J. | BUY | +144,700 | $20.43 | 02/04/2026 | 02/06/2026 |
| Huber Martin H. Jr. | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Jarrett Jennifer | BUY | +24,000 | Not reported | 02/04/2026 | 02/06/2026 |
| Goldan Keith A. | BUY | +118,000 | $20.43 | 02/04/2026 | 02/06/2026 |